Amino Acid Scanning at P5' within the Bowman-Birk Inhibitory Loop Reveals Specificity Trends for Diverse Serine Proteases.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
11 04 2019
Historique:
pubmed: 20 3 2019
medline: 15 9 2020
entrez: 20 3 2019
Statut: ppublish

Résumé

Sunflower trypsin inhibitor-1 (SFTI-1) is a 14-amino acid cyclic peptide that shares an inhibitory loop with a sequence and structure similar to a larger family of serine protease inhibitors, the Bowman-Birk inhibitors. Here, we focus on the P5' residue in the Bowman-Birk inhibitory loop and produce a library of SFTI variants to characterize the P5' specificity of 11 different proteases. We identify seven amino acids that are generally preferred by these enzymes and also correlate with P5' sequence diversity in naturally occurring Bowman-Birk inhibitors. Additionally, we show that several enzymes have divergent specificities that can be harnessed in engineering studies. By optimizing the P5' residue, we improve the potency or selectivity of existing inhibitors for kallikrein-related peptidase 5 and show that a variant with substitutions at 7 of the scaffold's 14 residues retains a similar structure to SFTI-1. These findings provide new insights into P5' specificity requirements for the Bowman-Birk inhibitory loop.

Identifiants

pubmed: 30888159
doi: 10.1021/acs.jmedchem.9b00211
doi:

Substances chimiques

Amino Acids 0
Trypsin Inhibitor, Bowman-Birk Soybean 0
Serine Proteases EC 3.4.-
Serine Endopeptidases EC 3.4.21.-
matriptase EC 3.4.21.-
Chymotrypsin EC 3.4.21.1
Factor XIIa EC 3.4.21.38
Trypsin EC 3.4.21.4
Thrombin EC 3.4.21.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3696-3706

Auteurs

Choi Yi Li (CY)

Institute for Molecular Bioscience , The University of Queensland , Brisbane QLD 4072 , Australia.

Simon J de Veer (SJ)

Institute for Molecular Bioscience , The University of Queensland , Brisbane QLD 4072 , Australia.

Andrew M White (AM)

Institute for Molecular Bioscience , The University of Queensland , Brisbane QLD 4072 , Australia.

Xingchen Chen (X)

Institute of Health and Biomedical Innovation , Queensland University of Technology , Brisbane QLD 4059 , Australia.

Jonathan M Harris (JM)

Institute of Health and Biomedical Innovation , Queensland University of Technology , Brisbane QLD 4059 , Australia.

Joakim E Swedberg (JE)

Institute for Molecular Bioscience , The University of Queensland , Brisbane QLD 4072 , Australia.

David J Craik (DJ)

Institute for Molecular Bioscience , The University of Queensland , Brisbane QLD 4072 , Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH